Literature DB >> 8751036

Transplacental transport of netobimin metabolites in ewes.

C Cristofol1, A Carretero, M Fernandez, M Navarro, J Sautet, J Ruberte, M Arboix.   

Abstract

Neither netobimin (NTB) nor its metabolite albendazole (ABZ) were found in plasma after an oral administration of 20 mg/kg of NTB to pregnant ewes during the last third of gestation. ABZ metabolites, albendazole sulphoxide (ABZSO) and albendazole sulphone (ABZSO2) were found in plasma 30 min and 2 h, respectively, after administration. The maximal plasma concentration (Cmax) of ABZSO was detected at 11.6 +/- 1.0 h and for ABZSO2 at 16.5 +/- 2.3 h. The plasma levels of the latter remained constant for 36 h, and decreased as ABZSO was removed from the blood. Jugular plasma levels of both metabolites did not differ significantly from those observed in the ovarian vein, suggesting that there were no exchanges between foetal and placental tissues. Both metabolite concentrations were similar in the umbilical vein and artery and in the amniotic and allantoic fluids, their values were half the maternal plasma concentration, leading to the conclusion that there was transplacental movement of metabolites. Both metabolites reached the foetus and could be responsible for the teratogenicity of NTB in sheep.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8751036     DOI: 10.1007/BF03189665

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  14 in total

1.  Effects of albendazole and albendazole sulfoxide on cultures of differentiating rodent embryonic cells.

Authors:  S G Whittaker; E M Faustman
Journal:  Toxicol Appl Pharmacol       Date:  1991-06-01       Impact factor: 4.219

2.  The effects of methyl-5(6)-butyl-2-benzimidazole carbamate (parbendazole) on reproduction in sheep and other animals. 8. Teratogenicity in the rat.

Authors:  W A Duncan; P G Lemon
Journal:  Cornell Vet       Date:  1974-01

3.  In vitro sulfoxidation of albendazole by ovine liver microsomes: assay and frequency of various xenobiotics.

Authors:  P Galtier; M Alvinerie; P Delatour
Journal:  Am J Vet Res       Date:  1986-02       Impact factor: 1.156

4.  Metabolism of albendazole in cattle, sheep, rats and mice.

Authors:  R J Gyurik; A W Chow; B Zaber; E L Brunner; J A Miller; A J Villani; L A Petka; R C Parish
Journal:  Drug Metab Dispos       Date:  1981 Nov-Dec       Impact factor: 3.922

5.  The disposition of albendazole in sheep.

Authors:  D R Hennessy; J W Steel; E Lacey; G K Eagleson; R K Prichard
Journal:  J Vet Pharmacol Ther       Date:  1989-12       Impact factor: 1.786

6.  Simultaneous pharmacokinetic modeling of a drug and two metabolites: application to albendazole in sheep.

Authors:  P Galtier; M Alvinerie; J L Steimer; P Francheteau; Y Plusquellec; G Houin
Journal:  J Pharm Sci       Date:  1991-01       Impact factor: 3.534

7.  Pharmacokinetic behaviour of netobimin and its metabolites in sheep.

Authors:  C E Lanusse; R K Prichard
Journal:  J Vet Pharmacol Ther       Date:  1990-06       Impact factor: 1.786

8.  Daily changes in foetal and maternal blood of conscious pregnant ewes, with catheters in umbilical and uterine vessels.

Authors:  R S Comline; M Silver
Journal:  J Physiol       Date:  1970-08       Impact factor: 5.182

9.  Albendazole : a comparison of relay embryotoxicity with embryotoxicity of individual metabolites.

Authors:  P Delatour; R C Parish; R J Gyurik
Journal:  Ann Rech Vet       Date:  1981

10.  Comparative pharmacokinetics of netobimin and albendazole in the one-humped camel (Camelus dromedarius).

Authors:  P Delatour; A Ouhsine; E Benoit
Journal:  Br Vet J       Date:  1989 Sep-Oct
View more
  1 in total

1.  Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.

Authors:  C Gokbulut; V Y Cirak; B Senlik
Journal:  Vet Res Commun       Date:  2006-10       Impact factor: 2.459

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.